JACOBSON PHARMA 02633Hong Kong Stock Exchange

0.9700.51%( -0.005 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
JACOBSON PHARMA (02633) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2016-09-21
Industry
Innovative Drugs & Biologics
Fiscal Year End
Mar 31
ISIN
KYG677291067

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)1.39B46/112
Net Profit (Last FY)266.31M38/125
ROE (Last FY)13.02%18/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
委员会 Executive Director
岑广业 Executive Director
严振亮 Executive Director
潘裕慧 Executive Director
黄志基 Non-Executive Director
林烱堂医生 Independent Non-Executive Director
陆庭龙 Independent Non-Executive Director
黄子恒 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-08-11.

About this page

This page shows JACOBSON PHARMA (02633) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.